Another one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinoma

dc.contributor.authorDi Nunno, Vincenzo
dc.contributor.authorMassari, Francesco
dc.contributor.authorMollica, Veronica
dc.contributor.authorCimadamore, Alessia
dc.contributor.authorSantoni, Matteo
dc.contributor.authorCheng, Liang
dc.contributor.authorLopez-Beltran, Antonio
dc.contributor.authorScarpelli, Marina
dc.contributor.authorMontironi, Rodolfo
dc.contributor.departmentPathology and Laboratory Medicine, School of Medicineen_US
dc.date.accessioned2020-02-24T13:57:42Z
dc.date.available2020-02-24T13:57:42Z
dc.date.issued2019-07
dc.eprint.versionFinal published versionen_US
dc.identifier.citationDi Nunno, V., Massari, F., Mollica, V., Cimadamore, A., Santoni, M., Cheng, L., Lopez-Beltran, A., Scarpelli, M., & Montironi, R. (2019). Another one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinoma. Annals of translational medicine, 7(Suppl 3), S137. https://doi.org/10.21037/atm.2019.06.06en_US
dc.identifier.urihttps://hdl.handle.net/1805/22114
dc.language.isoen_USen_US
dc.publisherAME Publishing Companyen_US
dc.relation.isversionof10.21037/atm.2019.06.06en_US
dc.relation.journalAnnals of Translational Medicineen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectNon-Clear Cell Renal Cell Carcinomaen_US
dc.subjectUncommon Diagnosesen_US
dc.subjectInterventional studiesen_US
dc.subjectCabozantiniben_US
dc.subjectTyrosine Kinase Inhibitoren_US
dc.subjectImmunotherapyen_US
dc.titleAnother one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinomaen_US
dc.typeArticleen_US
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685836/en_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
atm-07-S3-S137.pdf
Size:
203.88 KB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: